Choice and Timing of Antithrombotic after Ischemic Stroke, Intracerebral Hemorrhage or Cerebral Venous Thrombosis.
Publication
, Journal Article
Ryan, D; Girotra, T; Feng, W
Published in: CNS Neurol Disord Drug Targets
2024
Stroke is a multifactorial vascular disease and remains a leading cause of disability in the United States. Strokes can be ischemic or hemorrhagic in nature and secondary to arterial or venous disease, making determining the etiology and secondary prevention strategy important for preservation of the injured brain, prevention of recurrent strokes, and in the maintenance of good functional outcomes for patients impacted by stroke. In this narrative review, we provide a synopsis of the available medical evidence surround selection, timing, and choice of therapy, including utilization of left atrial appendage closure, in patients with ischemic, hemorrhagic or venous stroke.
Duke Scholars
Published In
CNS Neurol Disord Drug Targets
DOI
EISSN
1996-3181
Publication Date
2024
Volume
23
Issue
2
Start / End Page
135 / 152
Location
United Arab Emirates
Related Subject Headings
- Neurology & Neurosurgery
- 3214 Pharmacology and pharmaceutical sciences
- 3209 Neurosciences
- 1115 Pharmacology and Pharmaceutical Sciences
- 1109 Neurosciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Ryan, D., Girotra, T., & Feng, W. (2024). Choice and Timing of Antithrombotic after Ischemic Stroke, Intracerebral Hemorrhage or Cerebral Venous Thrombosis. CNS Neurol Disord Drug Targets, 23(2), 135–152. https://doi.org/10.2174/1871527322666230309100626
Ryan, Dylan, Tarun Girotra, and Wuwei Feng. “Choice and Timing of Antithrombotic after Ischemic Stroke, Intracerebral Hemorrhage or Cerebral Venous Thrombosis.” CNS Neurol Disord Drug Targets 23, no. 2 (2024): 135–52. https://doi.org/10.2174/1871527322666230309100626.
Ryan D, Girotra T, Feng W. Choice and Timing of Antithrombotic after Ischemic Stroke, Intracerebral Hemorrhage or Cerebral Venous Thrombosis. CNS Neurol Disord Drug Targets. 2024;23(2):135–52.
Ryan, Dylan, et al. “Choice and Timing of Antithrombotic after Ischemic Stroke, Intracerebral Hemorrhage or Cerebral Venous Thrombosis.” CNS Neurol Disord Drug Targets, vol. 23, no. 2, 2024, pp. 135–52. Pubmed, doi:10.2174/1871527322666230309100626.
Ryan D, Girotra T, Feng W. Choice and Timing of Antithrombotic after Ischemic Stroke, Intracerebral Hemorrhage or Cerebral Venous Thrombosis. CNS Neurol Disord Drug Targets. 2024;23(2):135–152.
Published In
CNS Neurol Disord Drug Targets
DOI
EISSN
1996-3181
Publication Date
2024
Volume
23
Issue
2
Start / End Page
135 / 152
Location
United Arab Emirates
Related Subject Headings
- Neurology & Neurosurgery
- 3214 Pharmacology and pharmaceutical sciences
- 3209 Neurosciences
- 1115 Pharmacology and Pharmaceutical Sciences
- 1109 Neurosciences